
|Videos|September 19, 2016
When Should Patients Switch from Statins to PCSK9 Inhibitors?
Author(s)Lauren Santye, Assistant Editor
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.
Advertisement
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
2
McKesson ideaShare 2026: Health Mart and Health Mart Atlas’ Role in Supporting Independent Pharmacies in 2026
3
McKesson ideaShare 2026: Why Automation and AI Are Reshaping the Dispensing Experience
4
ADA 2026: Lipid Management and Cardiovascular Prevention Updates for People With Diabetes
5




















































































































